Active Ingredient(s): Metyrosine
FDA Approved: * October 3, 1979
Pharm Company: * MERCK
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Demser Overview

Metirosine (INN and BAN; α-Methyltyrosine, Metyrosine USAN, AMPT) is an antihypertensive drug. It inhibits the enzyme tyrosine hydroxylase and, therefore, catecholamine synthesis, which, as a consequence, depletes the levels of the catecholamines dopamine, adrenaline and noradrenaline in the body. It is available as a generic medication.[1] Contents 1 Clinical use 2 See also 3 References 4 External links Clinical use Metirosine has been shown to suppress catecholam...

Read more Demser Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source:

Recent Demser Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Capsule: 250mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Demser: (1 result)

Sorted by National Drug Code
  • 25010-305 Demser 250 mg Oral Capsule by Aton Pharma, Inc.

Other drugs which contain Metyrosine or a similar ingredient: (1 result)